| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.33 | 0.003 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.48 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |